Form 8-K - Current report:
SEC Accession No. 0001104659-25-055248
Filing Date
2025-06-02
Accepted
2025-06-02 08:30:24
Documents
14
Period of Report
2025-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516546d2_8k.htm   iXBRL 8-K 35500
2 EXHIBIT 99.1 tm2516546d2_ex99-1.htm EX-99.1 7812
6 GRAPHIC tm2516546d2_ex99-1img001.jpg GRAPHIC 5051
  Complete submission text file 0001104659-25-055248.txt   221994

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tela-20250530.xsd EX-101.SCH 3011
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tela-20250530_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tela-20250530_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2516546d2_8k_htm.xml XML 3681
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Filer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39130 | Film No.: 251013219
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)